Anticancer

Anticancer
Author: David Servan-Schreiber
Publsiher: Penguin Books
Total Pages: 288
Release: 2017-10-03
ISBN 10: 9780452295728
ISBN 13: 0452295726
Language: EN, FR, DE, ES & NL

Anticancer Book Review:

The revolutionary, New York Times bestselling guide to the powerful lifestyle changes that fight and prevent cancer--an integrative approach based on the latest scientific research "A common-sense blueprint for healthy living." --Chicago Tribune "Resonating with cancer support communities and recommended nationwide." --Los Angeles Times "Life affirming . . . filled with practical advice." --The Seattle Times David Servan-Schreiber was a rising neuroscientist with his own brain imaging laboratory when, in the middle of an equipment test, he discovered a tumor the size of a walnut in his own brain. Forced to confront what medicine knows about cancer, and all that we still do not know, Servan-Schreiber marshaled his will to live and set out to understand the complex inner workings of the body's natural cancer-fighting capabilities. He soon found himself on a decades-long journey from disease and relapse into scientific exploration and, finally, a new view of health. Anticancer is at once the moving story of one doctor's inner and outer search for wellness and a radical exposition of the roles that lifestyle, environment, and trauma play in our health. Drawing on the latest research in integrative medicine that blends conventional and alternative approaches, Servan-Schreiber concisely explains what makes cancer cells thrive, what inhibits them, and how we can empower ourselves to prevent their growth. His advice details how to develop a science-based anticancer diet (and the small changes that can make a big difference); how to reap the benefits of exercise, yoga, and meditation; which toxic, unsafe products to replace in your home; and how to stave off the effects of helplessness and unhealed wounds to regain balance. Anticancer's synthesis of science and personal experience marks a transformation in the way we understand and confront cancer. A long-running bestseller that has changed the lives of millions around the world, Anticancer remains a pioneering and peerless resource, an inspirational and revolutionary guide to "a new way of life."

The Anticancer Drugs

The Anticancer Drugs
Author: William B. Pratt,William D. Ensminger,Raymond W. Ruddon
Publsiher: Oxford University Press, USA
Total Pages: 352
Release: 1994
ISBN 10: 9780195067392
ISBN 13: 0195067398
Language: EN, FR, DE, ES & NL

The Anticancer Drugs Book Review:

This is an up-to-date review of the pharmacology, mechanisms of action, development of resistance, and toxicity of cancer chemotherapeutic agents. A rationale for their clinical use, based on cancer cell biology, is given for each class of drugs.

Medicinal Chemistry of Anticancer Drugs

Medicinal Chemistry of Anticancer Drugs
Author: Carmen Avendano,J. Carlos Menendez
Publsiher: Elsevier
Total Pages: 768
Release: 2015-06-11
ISBN 10: 0444626670
ISBN 13: 9780444626677
Language: EN, FR, DE, ES & NL

Medicinal Chemistry of Anticancer Drugs Book Review:

Medicinal Chemistry of Anticancer Drugs, Second Edition, provides an updated treatment from the point of view of medicinal chemistry and drug design, focusing on the mechanism of action of antitumor drugs from the molecular level, and on the relationship between chemical structure and chemical and biochemical reactivity of antitumor agents. Antitumor chemotherapy is a very active field of research, and a huge amount of information on the topic is generated every year. Cytotoxic chemotherapy is gradually being supplemented by a new generation of drugs that recognize specific targets on the surface or inside cancer cells, and resistance to antitumor drugs continues to be investigated. While these therapies are in their infancy, they hold promise of more effective therapies with fewer side effects. Although many books are available that deal with clinical aspects of cancer chemotherapy, this book provides a sorely needed update from the point of view of medicinal chemistry and drug design. Presents information in a clear and concise way using a large number of figures Historical background provides insights on how the process of drug discovery in the anticancer field has evolved Extensive references to primary literature

Anticancer Drug Development

Anticancer Drug Development
Author: Bruce C. Baguley,David J. Kerr
Publsiher: Elsevier
Total Pages: 397
Release: 2001-11-17
ISBN 10: 9780080490441
ISBN 13: 0080490441
Language: EN, FR, DE, ES & NL

Anticancer Drug Development Book Review:

Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death. Detailed descriptions of sources for new drugs and methods for testing and clinical trial design are also provided. One work that can be consulted for all aspects of anticancer drug development Concise reviews of research fields, combined with practical scientific detail, written by internationally respected experts A wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death Detailed descriptions of the sources of new anticancer drugs, including combinatorial chemistry, phage display, and natural products Discussion of how new drugs can be tested in preclinical systems, including the latest technology of robotic assay systems, cell culture, and experimental animal techniques Hundreds of references that allow the reader to access relevant scientific and medical literature Clear illustrations, some in color, that provide both understanding of the field and material for teaching

Medicinal Chemistry of Anticancer Drugs

Medicinal Chemistry of Anticancer Drugs
Author: Carmen Avendano,J. Carlos Menendez
Publsiher: Elsevier
Total Pages: 400
Release: 2008-06-04
ISBN 10: 9780080559629
ISBN 13: 008055962X
Language: EN, FR, DE, ES & NL

Medicinal Chemistry of Anticancer Drugs Book Review:

Antitumor chemotherapy is nowadays a very active field of research, and a huge amount of information on the topic is generated every year. Although many books are available that deal with clinical aspects of cancer chemotherapy, this book addresses the need for an updated treatment from the point of view of medicinal chemistry and drug design. The focus of Medicinal Chemistry of Anticancer Drugs is on the mechanism of action of antitumor drugs from the molecular point of view and on the relationship between chemical structure and chemical and biochemical reactivity of antitumor agents, aiming at the rationalization of the action of this type of drug, which would allow the design of new active structures. * Explains the biological basis of cancer treatment and the role of chemists in improving anticancer drugs * Provides the historical background and serves as a comprehensive and practical guide on cancer research and anticancer drug development * Includes coverage of different approaches to treating cancer, drug resistance, and a chapter on cancer prevention

Novel Anticancer Drug Protocols

Novel Anticancer Drug Protocols
Author: John K. Buolamwini,Alex A. Adjei
Publsiher: Springer Science & Business Media
Total Pages: 372
Release: 2003
ISBN 10: 1592593801
ISBN 13: 9781592593804
Language: EN, FR, DE, ES & NL

Novel Anticancer Drug Protocols Book Review:

This book not only surveys the whole arena of novel anticancer drug targets, but also presents a wide-ranging selection of cuttingedge techniques currently being applied throughout novel antitumor drug discovery and development. The methods are applied to experiments involving such topics as immunotherapy, angiogenesis, cancer metastasis, the cell cycle, signal transduction inhibitors, apoptosis, antibodies, antisense molecules, microarray gene expression, flow cytometry, and PET imaging for cancer target validation. There are also proven methods for the preclinical identification of drug targets. Validate new drug targets both preclinically and clinically Identify novel anticancer drug targets in preclinical stages Follow proven instructions to obtain successful results and avoid failure.

Anticancer Therapeutics

Anticancer Therapeutics
Author: Sotiris Missailidis
Publsiher: John Wiley & Sons
Total Pages: 424
Release: 2008-10-13
ISBN 10: 0470697032
ISBN 13: 9780470697030
Language: EN, FR, DE, ES & NL

Anticancer Therapeutics Book Review:

Written by the winner of the 2008 Mike Price Fellowship "This volume provides a comprehensive overview of the wealth of information now available in this important and fast-moving subject." Anticancer Research, November - December 2008 This book provides a clear introduction to the area, with an overview of the various drug design and development approaches for cancer therapeutics and their progress in today’s multidisciplinary approach to cancer treatment. Clearly structured throughout, the book not only provides information on currently used molecular treatment approaches, but also describes the various agents that are currently at various stages of development and clinical trials, thus making them the drugs of tomorrow. The book goes on to present current therapeutic regimes including their indications and side effects, as well as their position in the international market in terms of sales and development costs. Furthermore, coverage of our advancement in the understanding of cancer biology and how this has driven the drug discovery process is clearly discussed. Modern drug discovery aspects, through genomic, proteomic and metabolomic approaches are referred to as well as combinatorial chemistry techniques and discovery of chemotherapeutic agents from plant extracts, re-use of old drugs and drugs from other indications, or de novo rational drug design. Including contributions from leading experts in the field, this book provides the reader with a complete overview of the various types of therapeutic agents, current and emerging, as well as other aspects associated with anticancer therapy, drug design, resistance and clinical trials in oncology.

Evidence based Anticancer Materia Medica

Evidence based Anticancer Materia Medica
Author: William C.S. Cho
Publsiher: Springer Science & Business Media
Total Pages: 442
Release: 2011-03-29
ISBN 10: 9789400705265
ISBN 13: 9400705263
Language: EN, FR, DE, ES & NL

Evidence based Anticancer Materia Medica Book Review:

Cancer is one of the leading killers in the world and the incidence is increasing, but most cancer patients and cancer survivors suffer much from the disease and its conventional treatments’ side effects. In the past, clinical data showed that some complementary and alternative medicine (CAM) possessed anticancer abilities, but some clinicians and scientists have queried about the scientific validity of CAM due to the lack of scientific evidence. There is great demand in the knowledge gap to explore the scientific and evidence-based knowledge of CAM in the anticancer field. With this aim, a book series is needed to structurally deliver the knowledge to readers. Recently there have been encouraging results from both laboratory experiments and clinical trials demonstrating the anticancer effects of herbal medicine. There is considerable interest among oncologists and cancer researchers to find anticancer agents in herbal medicine. This volume is a specialised book presenting the up-to-date scientific evidence for anticancer herbal medicine. This unique book provides an overview of the anticancer herbal medicines and remedies, as well as a detailed evidence-based evaluation of 18 common anticancer herbal medicines covering their biological and pharmacological properties, efficacies, herb-drug interactions, adverse effects, pre-clinical studies, and clinical applications. Gathering international opinion leaders’ views, this volume will contribute great to the cancer, academic, and clinical community by providing evidence-based information on the anticancer efficacy of herbal medicine. Readership Oncologists, cancer researchers, pharmacologists, pharmaceutical specialists, Chinese medicine practitioners, medical educators, postgraduates and advanced undergraduates in biomedical disciplines, cancer caregivers, cancer patients.

Organ Directed Toxicities of Anticancer Drugs

Organ Directed Toxicities of Anticancer Drugs
Author: Miles P. Hacker,John S. Lazo,Thomas R. Tritton
Publsiher: Springer Science & Business Media
Total Pages: 254
Release: 2012-12-06
ISBN 10: 1461320232
ISBN 13: 9781461320234
Language: EN, FR, DE, ES & NL

Organ Directed Toxicities of Anticancer Drugs Book Review:

The addition of chemotherapy as an effective means to treat cancer has had a major impact on selected human malignancies. Due to a general inability to dif ferentiate between normal and neoplastic cells, little selectivity exists in currently used oncolytic drugs. Consequently, significant toxicity to the patient is expected when systemic cancer chemotherapy is chosen as an appropriate therapeutic in tervention. Much of this toxicity, such as damage to the bone marrow, gastroin testinal tract, or hair follicles, is predictable based upon the fact that anticancer drugs kill actively dividing cells. These types of toxicities, while serious, are usually manageable and reversible and are, therefore, not often considered to be dose limiting. Unfortunately, several of the most important anticancer drugs also damage tissues in which the growth fraction is relatively small. Such toxicities can not be predicted based on the chemical structure of the drugs, are often not detected in preclinical studies, and are encountered frequently for the first time in clinical studies. Further, unlike most of the proliferative-dependent toxicities, the unpre dicted toxicities are usually irreversible or only partially reversible upon cessation of drug administration. Because of this, the unpredicted toxicities are referred to as dose limiting. They represent a significant barrier to the ultimate efficacy of several of our most important anticancer drugs.

Cytotoxic Anticancer Drugs Models and Concepts for Drug Discovery and Development

Cytotoxic Anticancer Drugs  Models and Concepts for Drug Discovery and Development
Author: Frederick A. Valeriote,Thomas H. Corbett,Laurence H. Baker
Publsiher: Springer Science & Business Media
Total Pages: 409
Release: 1992-03-31
ISBN 10: 9780792316299
ISBN 13: 0792316290
Language: EN, FR, DE, ES & NL

Cytotoxic Anticancer Drugs Models and Concepts for Drug Discovery and Development Book Review:

Proceedings of the 22nd Annual Cancer Symposium, Detroit, Michigan, April 26-28, 1990.

Anticancer Genes

Anticancer Genes
Author: Stefan Grimm
Publsiher: Springer
Total Pages: 283
Release: 2014-07-08
ISBN 10: 144716458X
ISBN 13: 9781447164586
Language: EN, FR, DE, ES & NL

Anticancer Genes Book Review:

This book discusses the emergence of a new class of genes with a specific anticancer activity. These genes, recently defined as “Anticancer Genes”, are reviewed in individual chapters on their mode of action, the specific cell death signals they induce, and the status of attempts to translate them into clinical application. Anticancer Genes provides an overview of this nascent field, its genesis, current state, and prospect. It discusses how Anticancer Genes might lead to the identification of a repertoire of signaling pathways directed against cellular alterations that are specific for tumor cells. With contributions from experts worldwide, Anticancer Genes is an essential guide to this dynamic topic for researchers and students in cancer research, molecular medicine, pharmacology and toxicology and genetics as well as clinicians and clinical researchers interested in the therapeutic potential of this exciting new field.

Macromolecular Anticancer Therapeutics

Macromolecular Anticancer Therapeutics
Author: L. Harivardhan Reddy,Patrick Couvreur
Publsiher: Springer Science & Business Media
Total Pages: 500
Release: 2010-03-20
ISBN 10: 9781441905079
ISBN 13: 1441905073
Language: EN, FR, DE, ES & NL

Macromolecular Anticancer Therapeutics Book Review:

In spite of the development of various anticancer drugs, the therapy of cancer has remained challenging for decades. The current therapy of cancer is overwhelmed because of the inability to deliver therapeutics to all regions of a tumor in effective therapeutic concentrations, intrinsic or acquired resistance to the treatment with currently available agents via genetic and epigenetic mechanisms, and toxicity. As a result, cancer therapy using conventional therapeutics and different types of treatment regimens using this therapeutics has not led to a convincing survival benefit of the patients. In this context, Macromolecular therapeutics offer several advantages over conventional low molecular therapeutics by various ways such as, enable the use of larger doses of these agents by limiting the toxicity, by enhanced permeability and retention into tumors, by tumor targeting using tumor-specific antibodies, by specific inhibition of oncogenes using anticancer oligonucleotides etc. Cancer treatment using this macromolecular therapeutics has considerably improved the survival benefit for patients. As a result, various macromolecular therapeutics are already commercialized or are under clinical development. Although we are far from a real magic bullet today, looking at the pace of research and current success in this field of macromolecular therapeutics, it appears that we are approaching a magic bullet for the efficient treatment of cancer. Thus, we believe that the subject of this book is very timely, and that the book will fill an unmet need in the market. This book is unique and assembles various types and aspects of macromolecular anticancer therapeutics for cancer therapy in one shell and conveys the importance of this interdisciplinary field to the broad audience. Thus, in a nutshell, this book details the basics of cancer, and various therapeutic strategies such as those based on macromolecular therapeutics hence can become an important reference for practitioners, oncologists, medical pharmacologists, medicinal chemists, biomedical scientists, experimental pharmacologists, pharmaceutical technologists, and particularly it can essentially become a handbook of macromolecular therapeutics for cancer therapy for graduates, post-graduates and Ph.D. students in these fields.

The Oral Anticancer Medicine Handbook

The Oral Anticancer Medicine Handbook
Author: Steve Williamson,Calum Polwart
Publsiher: Lulu.com
Total Pages: 193
Release: 2009-02-03
ISBN 10: 1409240444
ISBN 13: 9781409240440
Language: EN, FR, DE, ES & NL

The Oral Anticancer Medicine Handbook Book Review:

A reference guide to oral chemotherapy and oralanticancer medicines, including advice on safeprescribing, handling and administration.

RAPD Antimicrobial and Anticancer Activity of Musa Varieties in Kerala

RAPD  Antimicrobial and Anticancer Activity of Musa Varieties in Kerala
Author: Anu Augustine,S Geethalakshmi ,Prem Jose Vazhacharickal,P. E Sreejith,M. Sabu
Publsiher: Prem Jose
Total Pages: 329
Release:
ISBN 10:
ISBN 13: 9798601617628
Language: EN, FR, DE, ES & NL

RAPD Antimicrobial and Anticancer Activity of Musa Varieties in Kerala Book Review:

Banana is one of the most important food crops all over the world. There are around 365 varieties of bananas available throughout the world. Banana is a traditional medicine for diabetes, cancer, diarrhoea and also highly nutritional food crop. In this study, commonly used varieties of banana are taken for characterization by morphology and genotype which is based on International Plant Genetic Resources Institute and RAPD analysis. Five varieties were morphologically similar in parameters such as leaf habit, pseudo stem appearance and peel color. RAPD analysis proved that these varieties of banana are closely related which coincides with the morphological characterization. Also, this study is aimed at examining the anticancer activity of Musa acuminata variety of banana which is commonly consumed in southern part of India. Anticancer examination of the sample was performed for the hexane extract using DLA and MG-63 cell lines which showed a high degree of anticancer activity which was proved by the cytotoxic effect on the tumor cell lines. Phytochemicals present in the plant concentrate provoked cell apoptosis and smoother cell expansion to quickly partitioning malignancy cell lines. Among the five varieties analysed, Musa accuminata Colla variety shows increased level of anticancer activity in both cell lines. So it is anticipated that this variety can be used as medicine orally for cancer treatment.

Handbook of Anticancer Drugs from Marine Origin

Handbook of Anticancer Drugs from Marine Origin
Author: Se-Kwon Kim
Publsiher: Springer
Total Pages: 805
Release: 2014-11-27
ISBN 10: 3319071459
ISBN 13: 9783319071459
Language: EN, FR, DE, ES & NL

Handbook of Anticancer Drugs from Marine Origin Book Review:

This timely desk reference focuses on marine-derived bioactive substances which have biological, medical and industrial applications. The medicinal value of these marine natural products are assessed and discussed. Their function as a new and important resource in novel, anticancer drug discovery research is also presented in international contributions from several research groups. For example, the potential role of Spongistatin, Apratoxin A, Eribulin mesylate, phlorotannins, fucoidan, as anticancer agents is explained. The mechanism of action of bioactive compounds present in marine algae, bacteria, fungus, sponges, seaweeds and other marine animals and plants are illustrated via several mechanisms. In addition, this handbook lists various compounds that are active candidates in chemoprevention and their target actions. The handbook also places into context the demand for anticancer nutraceuticals and their use as potential anti-cancer pharmaceuticals and medicines. This study of advanced and future types of natural compounds from marine sources is written to facilitate the understanding of Biotechnology and its application to marine natural product drug discovery research.

Advances in Anticancer Agents in Medicinal Chemistry

Advances in Anticancer Agents in Medicinal Chemistry
Author: Michelle Prudhomme
Publsiher: Bentham Science Publishers
Total Pages: 485
Release: 2013-06-14
ISBN 10: 1608054969
ISBN 13: 9781608054961
Language: EN, FR, DE, ES & NL

Advances in Anticancer Agents in Medicinal Chemistry Book Review:

Advances in Anticancer Agents in Medicinal Chemistry is an exciting eBook series comprising a selection of updated articles previously published in the peer-reviewed journal Anti-Cancer Agents in Medicinal Chemistry. The second Volume of this eBook series gathers updated reviews on several classes of molecules exhibiting anticarcinogenic potential as well as some important targets for the development of novel anticancer drugs.

New Approaches to Natural Anticancer Drugs

New Approaches to Natural Anticancer Drugs
Author: Soodabeh Saeidnia
Publsiher: Springer
Total Pages: 106
Release: 2015-02-05
ISBN 10: 3319140272
ISBN 13: 9783319140278
Language: EN, FR, DE, ES & NL

New Approaches to Natural Anticancer Drugs Book Review:

This book provides an up-to-date review of recently identified natural anti-tumor compounds from various natural origins including plants, fungi, endophytic fungi and marine organisms. It also includes discussion of new areas such as biotechnology and nanoparticles. Chapters explain the challenges and developments in anti-cancer drug discovery approaches, traditional remedies for prevention and treatment of cancer, marine-derived anti-cancer compounds, and antibiotics used as anti-cancer agents, as well as different classes of terpenoids and carbohydrates, which have been the subject of discussion in this field as efficient anti-cancer candidates. This book will be a concise guide for researchers in the field of pharmaceutical sciences, students and residents in pharmacy and medicine as well as those researching phytochemistry and natural products.

Handbook of Anticancer Pharmacokinetics and Pharmacodynamics

Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
Author: Michelle A. Rudek,Cindy H. Chau,William D. Figg,Howard L. McLeod
Publsiher: Springer Science & Business Media
Total Pages: 836
Release: 2014-01-10
ISBN 10: 1461491355
ISBN 13: 9781461491354
Language: EN, FR, DE, ES & NL

Handbook of Anticancer Pharmacokinetics and Pharmacodynamics Book Review:

There are many steps on the road from discovery of an anticancer drug to securing its final approval by the Food and Drug Administration. In this thoroughly updated and expanded second edition of the Handbook of Anticancer Pharmacokinetics and Pharmacodynamics, leading investigators synthesize an invaluable overview of the experimental and clinical processes of anticancer drug development, creating a single indispensable reference that covers all the steps from the identification of cancer-specific molecular targets to screening techniques and the development and validation of bioanalytical methods to clinical trial design and all phases of clinical trials. The authors have included new material on phase 0 trials in oncology, organ dysfunction trials, drug formulations and their impact on anticancer drug PK/PD including strategies to improve drug delivery, pharmacogenomics and cancer therapy, high throughput platforms in drug metabolism and transport pharmacogenetics, imaging in drug development and nanotechnology in cancer. Authoritative and up-to-date, Handbook of Anticancer Pharmacokinetics and Pharmacodynamics, 2nd Edition provides in one comprehensive and highly practical volume a detailed step-by-step guide to the successful design and approval of anticancer drugs. Road map to anticancer drug development from discovery to NDA submission Discussion of molecular targets and preclinical screening Development and validation of bioanalytical methods Chapters on clinical trial design and phase 0, I, II, III clinical trials Pharmacokinetics, pharmacodynamics, pharmacogenomics, and pharmacogenetics of anticancer agents Review of the drug development process from both laboratory and clinical perspectives New technological advances in imaging, high throughput platforms, and nanotechnology in anticancer drug development

Anticancer Agents from Natural Products

Anticancer Agents from Natural Products
Author: Gordon M. Cragg,David G. I. Kingston,David J. Newman
Publsiher: CRC Press
Total Pages: 600
Release: 2005-06-13
ISBN 10: 1420039652
ISBN 13: 9781420039658
Language: EN, FR, DE, ES & NL

Anticancer Agents from Natural Products Book Review:

Plants, marine organisms, and microorganisms have evolved complex chemical defense and signaling systems that are designed to protect them from predators and provide other biological benefits. These organisms thus produce substances containing novel chemotypes that may have beneficial effects for humans. As collection methods improve and new screen

Anticancer Therapeutics

Anticancer Therapeutics
Author: Adam Todd,Paul W. Groundwater,Jason H. Gill
Publsiher: John Wiley & Sons
Total Pages: 448
Release: 2018-02-20
ISBN 10: 111862212X
ISBN 13: 9781118622124
Language: EN, FR, DE, ES & NL

Anticancer Therapeutics Book Review:

An integrated presentation of the basic science and clinical applications of anticancer agents Aimed at both undergraduate and postgraduate readers, this unique text provides readers with a fully-integrated presentation of all aspects of the science of anticancer drugs, including their chemistry, pharmacology, and clinical applications. After heart disease, cancer is the number one killer worldwide, and the tumor microenvironment is forever changing, creating an ever-greater demand for safer, more effective anticancer agents. In response to that demand, the $100 billion cancer drug market continues to grow, with our increased understanding of cancer leading to new drugs being used clinically almost every year. Anticancer Therapeutics is divided into three sections. Section 1 is an introduction to cancer and therapeutics, and covers the etiology and cellular and molecular basis of cancer. In Section 2, the authors focus on the anticancer agents — their discovery, synthesis, mode of action, mechanisms of resistance, and adverse reactions. Section 3 focuses on specific cancers, explaining how and why the various agents discussed in Section 2 are used, both individually and in combination, to treat different cancers. Integrates aspects of basic science, including chemistry and pharmacology and clinical medicine in relation to cancer therapeutics Written by an author team comprising specialists in medicinal chemistry, pharmacology, and oncology Features full-color images throughout illustrating how drugs bind to cellular targets and exert their pharmacological effect Divided into three sections, covering the etiology and cellular and molecular basis of cancer, anticancer agents, and drug applications for different cancers. Providing the reader with an integrated understanding of all aspects of the science of anticancer agents, this is an ideal textbook for undergraduates studying medicine, nursing, medicinal chemistry, pharmacy, pharmacology and other allied heath / life sciences. It is also a valuable bench reference for pharmacists, medics, and pharmaceutical researchers working in both academia and industry.